We successfully formed an inclusion complex between nylon-6 and R-cyclodextrin and attempted to use the formation and subsequent disassociation of the nylon-6/R-cyclodextrin inclusion complex to manipulate the polymorphic crystal structures, crystallinity, and orientation of nylon-6. Formation of the inclusion complex was verified by Fourier transform infrared (FTIR) spectroscopy, wideangle X-ray diffraction (WAXD), differential scanning calorimetry (DSC), and CP/MAS 13 C NMR. After obtaining the inclusion complex of nylon-6 and R-cyclodextrin, the sample was treated in an acid environment to remove the host R-cyclodextrin and coalesce the nylon-6 guest polymer. Examination of as-received and IC coalesced nylon-6 samples showed that the R-form crystalline phase of nylon-6 is the dominant component in the coalesced sample. X-ray diffraction patterns demonstrate that the γ-form is significantly suppressed in the coalesced sample. Along with the change in crystal form, an increase in crystallinity of ∼80% was revealed by DSC, and elevated melting and crystallization temperatures were also observed for the coalesced nylon-6 sample. FTIR spectroscopy revealed a significant degree of orientaion for the nylon-6 chains coalesced from their R-cyclodextrin inclusion complex crystals. Thermogravimetric analysis indicated that nylon-6 has an ∼30 °C higher thermal degradation temperature after modification by threading into and being extracted from its R-cyclodextrin inclusion complex.
Background: Triple-negative breast cancer (TNBC) is known to be associated with aggressive biologic features and a poor clinical outcome. Therefore, early detection of TNBC without missed diagnosis is a requirement to improve prognosis. Preoperative ultrasound features of TNBC may potentially assist in early diagnosis as characteristics of disease. Purpose: To retrospectively evaluate the sonographic features of TNBC compared to ER (+) cancers which include HER(-) and HER2 (+), and HER2 (+) cancers which are ER (-). Materials and Methods: From June 2012 through June 2014, sonographic features of 321 surgically confirmed ER (+) cancers (n=214), HER2 (+) cancers (n=66), and TNBC (n=41) were retrospectively reviewed by two ultrasound specialists in consensus. The preoperative ultrasound and clinicopathological features were compared between the three subtypes. In addition, all cases were analyzed using morphologic criteria of the ACR BI-RADS lexicon. Results: Ultrasonographically, TNBC presented as microlobulated nodules without microcalcification (p=0.034). A lower incidence of ductal carcinoma in situ (p<0.001), invasive tumor size that is>2 cm (p=0.011) and BI-RADS category 4 (p<0.001) were significantly associated with TNBC. With regard to morphologic features of 41 TNBC cases, ultrasonographically were most likely to be masses with irregular (70.7%) microlobulated shape (48.8%), be circumscribed (17.1%) or have indistinct margins (17.1%) and parallel orientation (68.9%). Especially TNBC microlobulated mass margins were more more frequent than with ER (+) (2.0%) and HER2 (+) (4.8%) cancers. Conclusions: TNBC have specific characteristic in sonograms. Ultrasonography may be useful to avoid missed diagnosis and false-negative cases of TNBC.
A novel and general method of modifying hydrophobic polysulfone (PSF) to produce highly hydrophilic surfaces was developed. This method is the low‐temperature plasma technique. Graft polymer‐modified surfaces were characterized with the help of Fourier transform infrared attenuated total reflection (FTIR–ATR) and X‐ray photoelectron spectroscopy (XPS). Study results demonstrated that poly(ethylene glycol) (PEG) could be grafted onto the PSF membrane surface by low‐temperature plasma. The hydrophilic character of the modified surfaces was increased in comparison with that of the parent membrane. The contact angle for a modified PSF membrane was reduced apparently. We analyzed the effectiveness of this approach as a function of plasma operating variables including plasma treatment power and treatment time. Hence, plasma‐induced graft polymer modification of membranes can be used to adjust membrane performance by simultaneously controlling the surface hydrophilicity and hemocompatibility. © 2000 John Wiley & Sons, Inc. J Appl Polym Sci 78: 979–985, 2000
Self-sorting is a common phenomenon in eukaryotic cells and represents one of the versatile strategies for the formation of advanced functional materials; however, developing artificial self-sorting assemblies within living cells remains challenging. Here, we report on the GSHresponsive in situ self-sorting peptide assemblies within cancer cells for simultaneous organelle targeting to promote combinatorial organelle dysfunction and thereby cell death. The self-sorting system was created via the design of two peptides E3C16E6 and EVM SeO derived from lipidinspired peptide interdigitating amphiphiles and peptide bola-amphiphiles, respectively. The distinct organization patterns of the two peptides facilitate their GSH-induced self-sorting into isolated nanofibrils as a result of cleavage of disulfide-connected hydrophilic domains or reduction of selenoxide groups. The GSH-responsive in situ self-sorting in the peptide assemblies within HeLa cells was directly characterized by super-resolution structured illumination microscopy. Incorporation of the thiol and ER-targeting groups into the self-sorted assemblies endows their simultaneous targeting of endoplasmic reticulum and Golgi apparatus, thus leading to combinatorial organelle dysfunction and cell death. Our results demonstrate the establishment of the in situ self-sorting peptide assemblies within living cells, thus providing a unique platform for drug targeting delivery and an alternative strategy for modulating biological processes in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.